z-logo
open-access-imgOpen Access
SUN-LB079 Acrostudy - Safety And Treatment Outcomes In 2221 Patients With Acromegaly Treated With Pegvisomant: Real World Experience
Author(s) -
Michael Wajnrajch,
Roy Gomez,
Judith Hey-Hadavi,
Nicky Kelepouris,
Joli van der Lans,
Cecilia CamachoHübner,
José Cara,
Natasa Rajicic,
Srinivas Rao Valluri,
Maria Fleseriu,
Roberto Salvatori,
Thierry Brue,
Ezio Ghigo,
Andrew A. Palladino
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sun-lb079
Subject(s) - pegvisomant , acromegaly , medicine , adverse effect , pediatrics , growth hormone , hormone

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here